Publication:
Hepatitis C and kidney disease: An overview and approach to management

Simple item page
dc.citedby29
dc.contributor.affiliationsFaculty of Medicine and Health Sciences
dc.contributor.affiliationsUniversiti Sains Islam Malaysia (USIM)
dc.contributor.affiliationsSelayang Hospital
dc.contributor.affiliationsUniversity of Malaya (UM)
dc.contributor.authorAzmi A.N.en_US
dc.contributor.authorTan S.-S.en_US
dc.contributor.authorMohamed R.en_US
dc.date.accessioned2024-05-28T08:36:43Z
dc.date.available2024-05-28T08:36:43Z
dc.date.issued2015
dc.description.abstractHepatitis C infection and chronic kidney disease are major health burden worldwide. Hepatitis C infection is associated with a wide range of extra-hepatic manifestations in various organs including the kidneys. A strong association between hepatitis C and chronic kidney disease has come to light. Hemodialysis in supporting the end stage renal disease patients unfortunately carries a risk for hepatitis C infection. Despite much improvement in the care of this group of patients, the prevalence of hepatitis C infection in hemodialysis patients is still higher than the general population. Hepatitis C infection has a negative effect on the survival of hemodialysis and renal transplant patients. Treatment of hepatitis C in end stage renal disease patients using conventional or pegylated interferon with or without ribavirin remains a clinical challenge with low response rate, high dropout rate due to poor tolerability and many unmet needs. The approval of new direct acting antiviral agents for hepatitis C may dramatically change the treatment approach in hepatitis C infected patients with mild to moderate renal impairment. However it remains to be confirmed if the newer Hepatitis C therapies are safe in individuals with severe renal impairment. This review article discusses the relationship between hepatitis C and chronic kidney disease, describe the various types of renal diseases associated with hepatitis C and the newer as well as the existing treatments for hepatitis C in the context of this subpopulation of hepatitis C patients. � The Author(s) 2015.
dc.description.natureFinalen_US
dc.identifier.doi10.4254/wjh.v7.i1.78
dc.identifier.epage92
dc.identifier.issn19485182
dc.identifier.issue1
dc.identifier.scopus2-s2.0-84920895538
dc.identifier.spage78
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84920895538&doi=10.4254%2fwjh.v7.i1.78&partnerID=40&md5=69f2ce90d2cdc469a3aa339401f742f7
dc.identifier.urihttps://oarep.usim.edu.my/handle/123456789/9164
dc.identifier.volume7
dc.languageEnglish
dc.language.isoen_USen_US
dc.publisherBaishideng Publishing Group Coen_US
dc.relation.ispartofWorld Journal of Hepatology
dc.sourceScopus
dc.subjectChronic hepatitis Cen_US
dc.subjectKidney diseaseen_US
dc.subjectManagementen_US
dc.titleHepatitis C and kidney disease: An overview and approach to managementen_US
dc.title.alternativeWorld J. Hepatol.en_US
dc.typeArticleen_US
dspace.entity.typePublication

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Hepatitis C and kidney disease- An overview and approach to management.pdf
Size:
1001.86 KB
Format:
Adobe Portable Document Format
Download

Collections

Scopus